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Seven outbreaks involving increasing numbers of 
banded mongoose troops and high death rates have been 
documented. We identiﬁ  ed a Mycobacterium tuberculosis 
complex pathogen, M. mungi sp. nov., as the causative 
agent among banded mongooses that live near humans in 
Chobe District, Botswana. Host spectrum and transmission 
dynamics remain unknown.
A 
previously unidentiﬁ  ed Mycobacterium tuberculosis 
complex pathogen has emerged in banded mongooses 
(Mungos mungo) in Botswana; we named the pathogen 
mongoose bacillus, or M. mungi sp. nov. This pathogen 
causes high mortality rates among banded mongooses that 
live in close association with humans because these ani-
mals live in human-made structures and scavenge human 
waste, including feces.
Banded mongooses are social, fossorial, viverids that 
feed on invertebrates and small mammals including sub-
terranean species (1). We initially identiﬁ  ed tuberculosis 
(TB) disease in banded mongooses in 2000. The outbreak 
appeared to spread as a point-source infection between 
mongoose troops living in close association with humans 
and human waste; infection spread through towns and the 
associated national park (2). During 2000–2010, a total of 
7 outbreaks occurred (increasing in duration), mongoose 
troop involvement increased, and the spatial and temporal 
connection between cases decreased. Infected mongoose 
troops are now widely identiﬁ  ed across the landscape, in-
cluding protected areas and urban centers (Figure 1), and 
high mortality rates threaten the survival of smaller troops. 
In this study area of Chobe District, Botswana, TB has been 
identiﬁ  ed in only humans and mongooses. Strain assess-
ment of human TB has not been conducted; the full host 
spectrum and transmission dynamics of this pathogen, cur-
rently unknown, are the focus of our ongoing research.
The Study
During 2000–2010 in Chobe District, Botswana, we 
performed 38 necropsies on macroscopically TB-positive 
mongooses, of which 18 were further evaluated and TB was 
conﬁ  rmed by histopathologic examination. An in-depth his-
tologic evaluation was performed on a subsample of 8 of 
these animals from the 2008 outbreak. The most striking fea-
ture identiﬁ  ed in the sick mongooses was anorexia, followed 
by nasal distortion and, less commonly, erosions of the nasal 
planum with involvement of the hard palate. For 7 of the 8 
TB-positive animals examined intensively, macroscopic le-
sions were noted on the nasal planum. Histologic examina-
tion detected unequivocal TB lesions in the skin of the nose 
and the anterior nasal mucosa. Our ﬁ  ndings suggested entry 
of the organism through erosions on the nasal planum, per-
haps in association with abrasions, which might occur during 
foraging. Such lesions were present in the hairless parts of 
the nose tip of most TB-infected mongooses. Furthermore, 
granulomatous inﬂ  ammation and mycobacterial organisms 
were found in the dermis of the skin directly below these 
erosions. Inﬂ  ammation and organisms were present in some 
cases in the nasal mucosa, but erosion was not found. Thus, 
organisms could not have been in the lumen of the nasal 
cavity. This ﬁ  nding is consistent with pneumonic TB being 
present in only a few advanced cases of disseminated TB. 
This pattern was consistent among all animals examined 
postmortem during the study period. Histologically, the TB 
pneumonia was determined to be hematogenous rather than 
bronchogenous (i.e., by inhalation); thus, no evidence for 
aerosol transmission was found. Rather, pathogen invasion 
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Figure 1. Locations of infected and unaffected banded mongoose 
troops and human infrastructural development, Chobe District, 
Botswana.M. tuberculosis Complex Pathogen 
appears to have occurred through the nasal planum of the 
mongoose, and hematogenous or lymphatic spread through 
the body was a strikingly unique feature of this particular 
M. tuberculosis complex organism.
Samples from histologically positive mongooses were 
positive by PCR for the MPB70 target, IS6110 element, 
and 16S rDNA, indicating that the infective organism was 
a member of the M. tuberculosis complex (3,4). Samples 
were further evaluated with an M. tuberculosis complex–
speciﬁ  c multiplex PCR (5), which provided distinct results, 
differing clearly from those for other members of the M. 
tuberculosis complex (Table 1).
The gyrB gene (encoding for gyrase B) sequence, used 
to identify M. tuberculosis complex member–speciﬁ  c se-
quence single-nucleotide polymorphisms (SNPs) (6), iden-
tiﬁ  ed the position of the organism as being situated between 
dassie bacillus and M. africanum subtype 1(a) and showed 
no detectable new SNPs (Figure 2, panel A). Ampliﬁ  cation 
of RD701 and RD702 and lack of SNPs in rpoB and hsp65 
genes demonstrated that this organism was not a member 
of the M. africanum subtype 1(a) sublineage (6,11) (Figure 
2, panel A).
Three markers were evaluated to deﬁ  nitively exclude 
the organism from being dassie bacillus: N-RD25das dele-
tion, RD1das deletion, and SNP 389 in the gene Rv0911 (6). 
The N-RD25das ampliﬁ  cation gave the right product for the 
presence of a deletion in this region, and further sequencing 
conﬁ  rmed that it contained a deletion in the same position 
as N-RD25das; however, sequencing of Rv0911 showed no 
SNP at position 389, indicating that this organism was not 
dassie bacillus. As a ﬁ  nal test, we ampliﬁ  ed the RD1das re-
gion but were unable to amplify a product from the mon-
goose isolates. We redesigned primers to amplify a smaller 
region of different diagnostic sizes (248 bp when RD1das 
is deleted and 318 bp when RD1 is intact) but still had no 
ampliﬁ  cation. This ﬁ  nding indicates that the RD1 region is 
deleted in this organism but that the deletion is larger than 
that of the dassie bacillus.
We then used spoligotyping analysis (12) to further 
evaluate mongoose samples and identiﬁ  ed a unique spoli-
gotype pattern with no known matches in the international 
spoligotyping database SpolDB4 (9) or the M. bovis–spe-
ciﬁ  c spoligotype database (www.Mbovis.org) (Figure 2, 
panel B). This pattern was constant during 2000–2009 in 
different mongoose troops and locations (online Technical 
Appendix, www.cdc.gov/EID/content/16/8/1296-Techapp.
pdf). This unique spoligotyping pattern will enable identiﬁ  -
cation of M. mungi in future TB surveillance programs.
For these same isolates, the full set of 24 mycobac-
terial interspersed repetitive unit–variable number tandem 
repeats (13) identiﬁ  ed a pattern that was unique compared 
with others in the international database at www.miru-vn-
trplus.org (Table 2). Our examination also included dassie 
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Table 1. Genomic regions of difference of Mycobacterium tuberculosis complex members compared with M. mungi*
Mycobacterium species
Region of difference
RD1
BCG RD4 RD9  RD12  RD1
mic RD2
seal
M. canettii PPPAPP
M. tuberculosis PPPPPP
M. africanum PPAPPA
M. microti PPAPAP
M. pinnipedii PPAPPA
M. caprae PPAAPP
M. bovis PAAAPP
M. bovis BCG AAAAPP
M. mungi PPAPPP
*Determined by PCR amplification (5). RD, region of difference; RD1
BCG, M. bovis BCG–specific RD1; RD1
mic, M. microti–specific RD1; RD2
seal, M. 
pinnipedii–specific RD2; P, present; A, absent. 
Figure 2. A) Schematic of the phylogenetic relationships among 
Mycobacterium tuberculosis complex species, including newly 
discovered M. mungi, based on the presence or absence of regions 
of difference (gray boxes) as well as speciﬁ  c  single-nucleotide 
polymorphisms (white boxes), modiﬁ   ed from (7). B) Spoligotype 
of M. mungi compared with representative spoligotypes from other 
M. tuberculosis complex species (8–10).bacillus, which had not been previously analyzed. Evidence 
of multiple M. mungi substrains circulating between years 
and within social groups (6601B and 6600B) in the same 
outbreak year (Table 2) suggests complexity in M. mungi 
transmission and potential evolution of the organism over 
the past decade.
Conclusions
This newly identiﬁ   ed mycobacterial pathogen has 
many unique ecologic characteristics that set it apart from 
other members of the M. tuberculosis complex. First, it 
causes high numbers of deaths of banded mongooses, 
threatening local extinction of smaller social groups. Sec-
ond, rather than having a primary respiratory transmission 
route with direct transmission between individuals, as is 
characteristic of other M. tuberculosis complex species, M. 
mungi appears to infect banded mongooses by means of a 
nonrespiratory route through the nasal planum, suggestive 
of environmental transmission. Third, the time from clini-
cal presentation to death for affected mongooses is gener-
ally short (2–3 months) compared with that for other M. 
tuberculosis complex pathogens (more chronic infection, 
can take years to progress to death). Acute illness and high 
mortality rates, as seen in banded mongooses with M. mun-
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Table 2. Comparison of full 24-set MIRU-VNTR of selected Mycobacterium mungi isolates* 
Sample no.  1883  6601B  6606A  6600B  6875  – 8163/02 24 287/99 7739/01  5358/99  8490/00 H37Rv 
Year  isolated  2000 2002 2002 2004 2008  – –– – – – ––
Species
M. 
mungi
M. 
mungi
M. 
mungi
M. 
mungi
M. 
mungi DB M. a. OB 
M. 
microti M. p.
M. 
caprae
M. 
bovis M. t. 
MIRU 02   2 2 2 2 2 2 2 22 2 2 2 2
VNTR 0424/ 
Mtub04
3 3 3 3 3 2 4 23 3 4 2 2
VNTR 0577/ 
ETR-C
3 3 3 3 3 5 5 5 5 4 5 5 4
MIRU 04/ 
ETR-D
3 3 3 3 3 3 2 3 4 5 3 4 2
MIRU 40  1 1 1 1 1 2 2 2 2 2 2 2 1
MIRU 10   5 5 5 5 5 7 7 75 6 6 2 3
MIRU 16   3 3 3 3 3 3 4 4 6 4 2 4 2
VNTR 1955/ 
Mtub21
3 3 3 3 3 3 4 33 4 3 3 2
MIRU 20   2 2 2 2 2 2 2 2 1 2 2 2 2
VNTR 2163b/ 
QUB11b
0 No No No No 7 5 No 6 9 4 4 5
VNTR 2165/ 
ETR-A
6 6 No 6 6 6 6 3 9 9 5 4 3
VNTR 2347/ 
Mtub29
3 3 3 3 3 3 3 3 3 3 3 3 4
VNTR 2401/ 
Mtub30
4 4 4 4 4 3 4 44 4 4 4 2
VNTR 2461/ 
ETR-B
4 4 4 4 4 4 4 2 3 3 3 3 3
MIRU 23   4 4 4 4 4 4 4 44 4 4 4 6
MIRU 24   2 2 2 2 3 2 2 12 2 2 1 1
MIRU 26   4 4 3 3 4 5 4 4 2 2 4 3 3
MIRU 27   3 3 3 3 3 4 3 3 2 2 3 3 3
VNTR 3171/ 
Mtub34
3 3 3 3 3 3 3 33 3 2 3 3
MIRU 31/ 
ETR-E 
8/9 8/9 8/9 8/9 8/9 5 5 4 1 3 5 3 3
VNTR 3690/ 
Mtub39
2 No No No No 5 4 4 3 3 1 2 5
VNTR 4052/ 
QUB26
No No No No No 4 6 2 9 7 3 5 5
VNTR 4156/ 
QUB4156  
No No No No No 3 3 3 3 0 3 1 2
MIRU 39   2 2 2 2 2 2 22 2 2 2 22
*MIRU, mycobacterial interspersed repetitive unit; VNTR, variable number tandem repeats; DB, Dassie bacillus; M. a., M. africanum; OB, Oryx bacillus; 
M. p., M. pinnipedii; M. t., M. tuberculosis; –, not applicable.; no, no amplification. Gray shading highlights differences between the Mycobacterium 
tuberculosis complex species and M. mungi as well as variation within M. mungi samples evaluated. DB data supplied by S. Parsons. OB data supplied 
by P. Supply. M. africanum West African 2 strain 8163/02 (ST181), M. microti strain 287/99 (ST539), M. pinnipedii strain 7739/01, M. caprae strain 
5358/99 (ST647), M. bovis strain 8490/00 (ST482), and M. tuberculosis strain H37Rv data from www.miru-vntrplus.org.M. tuberculosis Complex Pathogen 
gi infection, have been associated with extremely isolated 
human communities newly exposed to TB (14).
Conventional laboratory culture, biochemical testing, 
and a limited molecular evaluation were insufﬁ  cient for 
differentiating M. mungi from M. tuberculosis (2). Organ-
ism differentiation required an extensive suite of addition-
al molecular assessments not available at that time, thus 
underscoring the difﬁ  culty of diagnosing M. tuberculosis 
complex agents correctly and the inability of most national 
health laboratories to do so. The fact that new host-adapted 
M. tuberculosis complex species continue to be identiﬁ  ed 
illustrates the diversity within the M. tuberculosis complex 
and stresses the need for sensitive techniques for species 
differentiation. The identiﬁ   cation of this previously un-
known pathogen within the M. tuberculosis complex iden-
tiﬁ  es new concerns for human and animal health and il-
lustrates the continuing scope of the threat posed by TB 
pathogens.
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